Thank you for joining us! We’ve launched this blog for healthcare professionals interested in advances in the molecular diagnosis for metastatic cancers. This blog will discuss results from CancerTYPE ID, a molecular classifier that provides a diagnosis of tumor type based on cell lineage. With a single diagnosis, additional information, such as guideline recommended biomarkers, may inform treatment decisions.
In addition to discussing ways in which molecular classification may improve clinical decision-making for metastatic cancers, this blog will also provide information on the latest advancements in diagnosing metastatic cancers from peer-reviewed journals and late-breaking data from scientific meetings.
Our hope is that you find the information presented here to be useful for your clinical practice. We encourage you to comment and be part of the dialogue, starting with: What are some topics of interest to you? Do you have specific questions about how molecular classification of metastatic cancers can have an impact on your clinical practice?
Share a diagnostic dilemma that you have faced recently.
Again, welcome! We look forward to sharing this information with you!
Want to learn more about CancerTYPE ID? Order a test? Start here.
Subscribe to our blog for updates.
Coming soon to the blog: “Resolution of Diagnostic Dilemmas in Oncology”